Macrolide antibiotics have an anti-inflammatory effect by suppressing lipopolysaccharide-induced IL-8 production. IL-8 secretion from monocytes is observed in Helicobacter pylori infection. Although cag gene products are known to induce IL-8 secretion, whether other bacterial substances can initiate the reaction is not determined. In this study, we show that clarithromycin induced down-regulation of Toll-like receptor 4 expression and did not lead to a decrease in IL-8 production and H. pylori lipopolysaccharide. However, Toll-like receptor 4 activation was possibly not the main cause in the induction of inflammation during H. pylori infection.
Introduction
Helicobacter pylori is one of the most common pathogens, which colonizes approximately 50% of the world population. The mechanism by which H. pylori induces gastric mucosal inflammation still remains unknown.
IL-8 is a chemokine mainly produced by activated monocytes [1] . Thus, IL-8 attracts inflammatory cells to the site of infection [2] . It has been reported that IL-8 is responsible for maintenance of chronic inflammation in gastritis caused by H. pylori [3, 4] . Adherence of H. pylori to gastric epithelial cells is required for the induction of IL-8 secretion, and one microbial constituent that regulates secretion of IL-8 is the cag pathogenecity island [5, 6] . Although IL-8 release has been linked to certain cag genes, the specific molecule that triggers epithelial pro-inflammatory gene expression is unrevealed.
Toll-like receptors (TLRs) are an evolutionarily conserved family of receptors that function in innate immunity via recognition of some invariant regions in bacteria molecules and termed pathogen-associated molecular patterns (PAMPs) [7] . TLR4 and TLR5 recognize lipopolysaccharide (LPS) and flagellin, respectively, which are released by a wide variety of gram-negative organisms [8, 9] . Several studies have demonstrated that LPS from H. pylori stimulates gastric epithelial cells to produce IL-8, which in turn elicits chronic gastritis [4] H. pylori is a flagellated organism, we can expect H. pylori to activate TLR5-mediated innate immunity.
Macrolides have an anti-inflammatory effect in addition to their antimicrobial properties [10] . Several studies have shown that macrolides suppress the production of several pro-inflammatory cytokines by bronchial epithelial cells, neutrophils, lymphocytes and monocytes [11, 12] . Clarithromycin has been shown to suppress the LPS signaling that leads to NF-jB [13] .
Here, we report that clarithromycin suppresses the expression of TLR4 mRNA from monocytes in H. pylori infection and suppressed TLR4 does not affect IL-8 secretion.
Materials and methods

Helicobacter pylori culturing
All the experiments were performed using the cagA+, vacA+ H. pylori strain 43504 (American Type Culture Collection) and clarithromycin-resistant H. pylori isolated from patients. H. pylori were plated onto Brucella agar supplemented with 5% horse blood (BBL, Becton Dickinson Microbiology, Cockeysville, MD, USA) and incubated at 37°C in a microaerophilic atmosphere using Campy Paks (BBL, BBL Microbiology Systems, Cockeysville, MD, USA). After 3 days, the bacteria were transferred into brain-heart infusion broth containing 10% horse serum and grown under the same conditions for 3 days to obtain the spiral H. pylori. Incubation in the brain-heart infusion broth was kept for another 7 days to obtain the coccoid H. pylori. Both forms of bacteria were centrifuged at 3000g for 25 min and rinsed with phosphate-buffered saline (PBS) 3 times. Then, the bacterial pellets were diluted in PBS to a concentration of 5 · 10 8 bacteria ml À1 .
Reagents
Escherichia coli LPS (E. coli serotype 055:B5, Sigma St. Louis, MO, USA) was subjected to an additional purification procedure as described by Hirschfeld et al. [14] . Briefly, LPS was extracted from H. pylori using the conventional phenol-water extraction method, i.e., LPS was obtained as precipitate from the aqueous phase. Subsequently, the precipitate was treated with 1 lg ml À1 of DNase and 1 lg ml À1 of RNase (Sigma Chemical Co., St. Louis, USA) at 30°C for 90 min at pH 7.5, followed by the addition of 1 lg ml À1 of trypsin (Wako Pure-Chemical Industries Ltd., Osaka, Japan) and incubation at 30°C for 90 min. Proteinase K (1 lg ml À1 ) from fungi (Wako Pure Chemical Industries Ltd., Osaka, Japan) was added and incubated for an additional 90 min. After the enzyme treatment, the solution was dialyzed against distilled water and lyophilized to obtain a second preparation. This preparation was treated with 45% phenol containing triethylamine and sodium deoxycholate (DOC), and LPS extracted in the aqueous phase was precipitated with ethanol by the DOC-phenol-water extraction method to obtain a third preparation. LPS preparations were subjected to sodium dodecyl sulfate-15% polyacrylamide gel electrophoresis, and visualized with a silver staining kit (Bio-Rad, Hercules, California, USA). In addition, electrophoretic transfer to polyvinylidene difluoride membranes was performed and protein was detected using a colloidal gold reagent with a gold enhancement kit (Bio-Rad).
Human peripheral blood monocytes
Peripheral blood was drawn from healthy volunteers. Peripheral blood mononuclear cells (PBMCs) were isolated by centrifugation on a Ficoll-sodium diatrizoate solution (Ficoll-Paque; Pharmacia Biotech, Uppsala, Sweden) and resuspended in RPMI 1640 medium supplemented with 10% heat-activated FCS. PBMCs were then plated on FCS-coated plates and incubated for 1 h at 37°C in a humidified 95% air/5% CO 2 atmosphere. Non-adherent cells were removed by washing with PBS. More than 90% of the adherent cells were morphologically identified as monocytes.
RT-PCR
PBMCs were grown to confluence in 6-well plates (1 · 10 6 cells per well). The cells were incubated with the spiral form of H. pylori, coccoid form of H. pylori or clarithromycin-resistant H. pylori (1 · 10 9 ) for 6 h. E. coli LPS and H. pylori LPS (1 lg ml À1 ) were added to the plate for TLR4 mRNA expression. A fixed concentration of clarithromycin (10 lg ml À1 ) was added to the culture medium to determine the effect on the TLRs expression and IL-8 secretion. Total cellular RNA was extracted from PBMCs using the acid guanidine thiocyanate-phenol-chloroform method according to the manufacturerÕs instructions. Reverse transcription was performed to generate cDNA using MMLV-reverse transcriptase (Gibco, Rockville, MD, USA). The mRNA expression of TLR4, TLR5 and IL-8 was determined by RT-PCR. The oligonucleotide primers for TLRS were as follows: TLR4 (forward); TLR4 (S) 5 0 -TGT CCC TGA ACC CTA TGA AC-3 0 , (reverse) 5 0 -GCC TTT TGA GAG ATT TGA GT-3 0 , TLR5 (forward); TLR5 (S) 5 0 -CAC GGA TGA AGA GG-3 0 , (reverse) 5 0 -CAG CCA TCT CTA AGG AAG TGT CTG C-3 0 . The temperature and time schedules were as follows: incubation for 5 min at 94°C followed by 30 cycles at 94°C for 30 s, at 55°C for 30 s, and at 72°C for 30 s. The PCR products were analyzed on 1% agarose gels. The densities of the PCR bands were measured by densitometry and compared to the density of the b-actin band.
IL-8 enzyme-linked immunosorbent assay
Human PBMC were incubated in a culture medium containing H. pylori or LPS with or without clarithromycin. After 6 h, the IL-8 protein concentration in the culture medium was measured by an IL-8 specific enzyme-linked immunosorbent assay (ELISA).
Statistical analysis
The experiments were performed at least 3 times independently. Data are expressed as means ± standard deviation (SD). The significant difference between the means was tested by StudentÕs two-tailed t test. A P value of <0.05 was considered statistically significant.
Results
Expression of TLR4 mRNA
TLR4 mRNA expression from PBMC was up-regulated by the spiral, coccoid and clarithromycin-resistant forms of H. pylori (Fig. 1) . The up-regulation of TLR4 mRNA was not detected from non-infected monocytes. The up-regulation of TLR4 mRNA was not significant when clarithromycin was added to the culture medium. Clarithromycin deteriorated the TLR4 mRNA expression of clarithromycin-resistant H. pylori-infected monocytes (Fig. 1). 
Expression of TLR4 by H. pylori LPS
To determine the expression of TLR4 mRNA from the monocytes, we extracted and purified LPS from H. pylori and co-cultured it with monocytes. The LPS extracted from the spiral, coccoid and clarithromycinresistant forms of H. pylori induced significant up-regulation of TLR4 mRNA expression from PBMCs (p < 0.05). TLR4 mRNA expression was the more prominent from PBMCs when it was incubated with E. coli LPS (Fig. 1) . The up-regulation of TLR4 mRNA by H. pylori LPS and E. coli LPS was not significant when clarithromycin was added to the culture medium (Fig. 1) . When clarithromycin was added to the culture media 30 min after adding E. coli LPS, down-regulation of TLR4 mRNA expression was observed, however, the expression of TLR4 was still significantly higher than control (p < 0.05).
Expression of TLR5 mRNA
We determined the ability of H. pylori to induce TLR5 mRNA expression. The expression of TLR5 mRNA was increased by the spiral form of H. pylori-infected PBMCs (p < 0.05, Fig. 2 ). In contrast, the expression of TLR5 mRNA by the coccoid form of H. pylori-infected cells Fig. 1 . TLR4 mRNA expression from PBMCs by E. coli LPS, H. pylori and H. pylori LPS with or without clarithromycin. E. coli LPS induced TLR4 mRNA expression was increased significantly (p < 0.05, lanes 2 and 3). The significant up-regulation of TLR4 was not induced when clarithromycin was added to the culture media. TLR4 mRNA expression was up-regulated significantly by the spiral, coccoid and clarithromycin-resistant forms of H. pylori (p < 0.05, lanes 5-7). The up-regulation of TLR4 mRNA was not significant when clarithromycin was added to the culture media (lanes 8-10) . The LPS extracted from the spiral, coccoid and clarithromycin-resistant forms of H. pylori induced the up-regulation of TLR4 mRNA expression from PBMCs (p < 0.05, lanes 11-13). The up-regulation of TLR4 mRNA by H. pylori LPS was not significant when clarithromycin was added to the culture media (lanes 14-16). * p < 0.05. did not differ from the control significantly (p > 0.05, Fig. 2 ). Co-culture with clarithromycin did not affect the expression of TLR5 mRNA (Fig. 2) . E. coli LPS did not induce TLR5 mRNA expression either.
IL-8 ELISA
We tested H. pylori-induced IL-8 secretion from PBMCs. H. pylori-induced IL-8 production was not significantly increased when compared to control samples. H. pylori LPS did not induce significant IL-8 production from PBMC. Clarithromycin co-culture did not affect the amount of IL-8 production induced by H. pylori and H. pylori LPS, however, IL-8 production was significantly increased by E. coli LPS (0.32 ± 0.02 ng ml À1 ) and suppressed by clarithromycin co-culture (0.076 ± 0.041 ng ml À1 , p < 0.05, Fig. 3 ). Suppression of IL-8 was more efficient when clarithromycin was added to the culture prior to E. coli LPS addition. These data indicate that clarithromycin suppresses the TLR4 expression through LPS stimulation; however, suppressed TLR4 does not affect IL-8 production significantly in H. pylori infection.
Discussion
The innate immune system recognizes pathogen-associated molecular patterns (PAMPs) that are expressed on the infectious agent. TLRs recognize PAMPs and mediate the expression of inflammatory cytokines [15, 16] . The TLR family consists of at least 10 members (TLR1-TLR10), and is still expanding [17, 18] . These different TLRs appear to perform critical roles in the activation of the immune response to different PAMPs [18] . Although each TLR has specificity of recognition of PAMPs, it is suggested that the immune response to pathogens is the sum of signals from multiple TLRs and other co-operating receptor molecules [19] .
Even with the high prevalence of H. pylori infection, the vast majority of colonized persons hardly eliminate H. pylori unless specific antibiotics are applied; thus, the features of H. pylori-induced gastritis can persist for decades. This is in marked contrast to inflammatory reactions induced by other gram-negative enteric bacteria, which either resolve within weeks or progress to eliminate the host. From this aspect, the mucosal immune reaction to H. pylori might be insufficient to eliminate these bacteria from gastric mucosa [20] .
Although IL-8 release in H. pylori infection has been linked to certain cag genes, the specific molecule that triggers epithelial pro-inflammatory gene expression remains unknown [21, 22] . Flagellin and LPS are the major determinants of IL-8 secretion that result from flagellated gram-negative bacteria [7, 23] . However, IL-8 production by gastric epithelial cells was not regulated by H. pylori flagellin or LPS [24, 25] . Monocytes are the main cells that produce IL-8 [1] and they express both TLR4 and TLR5 [26] , therefore, we investigated whether H. pylori LPS and flagellin could play a role in inducing IL-8 production from PBMCs instead of from gastric epithelial cells. However, our findings indicated that H. pylori-induced TLR4 and TLR5 mRNA expression did not regulate IL-8 production significantly. Even though the results were not statistically significant, the value of IL-8 production induced by the spiral form of H. pylori (0.102 ± 0.017) and H. pylori LPS (0.086 ± 0.014) was higher than control (0.023 ± 0.005, Fig. 3) , and their values were decreased when macrolide was add to the culture. Down-regulation of TLR4 mRNA expression by clarithromycin did not affect the result of IL-8 production by PBMCs in H. pylori infection. In contrast, production of IL-8 induced by E. coli LPS was higher and suppressed by clarithromycin.
The role of H. pylori LPS is still unclear. Although the LPS from most of gram-negative bacteria activate via TLR4, LPS from H. pylori seems to be a weak TLR4 activator or a non-stimulator. The importance of TLR2 to NF-jB activation in H. pylori infection has been reported [26] . However, the ligands for TLR2 are not elucidated clearly [27] . In agreement with our study, Mandell et al. [28] reported that H. pylori LPS did not play the main role in inducing inflammatory cytokines production while TLR4 activation by H. pylori LPS was observed. In contrast, Smith et al. [26] reported that the response to H. pylori LPS occurs via TLR2 and TLR4 activation was not reported in their study. The reason of discrepancy is unclear, however, the difference in the amount of LPS, incubation time and methods of measurement could make the different results. Long-term macrolide therapy was effective in diffuse panbronchiolitis and other chronic inflammatory diseases [29, 30] . Clarithromycin suppresses the LPS-induced IL-8 production in both monocytes and epithelial cells in a similar manner as in our studies [13] . It has been shown that clarithromycin suppresses LPS signaling at an earlier pathway than AP-1 and NF-jB activation, which is induced by LPS-induced TLR4 activation [13] .
In this study, TLR4 and TLR5 expression by H. pylori and its LPS did not affect significantly the amount of IL-8 production. However, IL-8 production was decreased when TLR4 mRNA was suppressed by clarithromycin when E. coli LPS stimulated PBMC. This result might be due to a weak ability of H. pylori and its LPS in activating TLR4 and TLR5. These results indicate that TLR4 and TLR5 may not play a main role in the H. pylori-associated inflammation and H. pylori LPS is not as pathogenic as E. coli LPS.
